I agree with everything you said except "very soon" as we (retail) always seem to overlook necessary steps that must be accomplished first, thus adding a great deal more time than we retail investors allow for share price to rise appreciably. I am not saying things could not change rapidly in the very near term, just that it is not a given.

Right now it is finalizing the pill for both B and K
Then getting both pills validated as "safe" by both FDA and EMA
Then doing a phase 2 trial for IBD indication(s) - Crohns and UC.
Or getting K pill into complementary trials with major current treatments

I sure hope we get an OM deal or word on how far we plan to take the indication ourselves thru further trials and to market.

I think Leo is working on making sure we have the finances for the above (hope the vote for new shares is aimed towards this) but time never seems to play towards the near term in biotech. Thus we wait.